Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients

Jong Won Choi, SangHoon Ahn, Junyong Park, Hye Young Chang, Ja Kyung Kim, Oidov Baatarkhuu, doyoung kim, KwangHyub Han, Chae Yoon Chon

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Most patients with hepatitis B e antigen (HBeAg)negative chronic hepatitis B have variants of the hepatitis B virus (HBV) that include mutations in the precore or core promoter regions of the HBV genome. The aim of this study was to investigate the patterns of precore and core promoter mutations and their relationship to HBeAg expression in Korean patients. Four hundred seventy-five Korean patients with chronic HBV infection between February 1995 and December 2003 were enrolled in this study. There were 236 HBeAg-positive and 239 HBeAg-negative patients. Blood samples were tested for HBsAg, anti-HBs, HBeAg, hepatitis B e antibody (anti-HBe), liver function tests, and serum HBV DNA. Mutations in the precore and core promoter regions were determined by direct sequencing. In the core promoter region, the C1740, C1753, T1762/A1764, and T1766 mutations were associated with HBeAg escape (all; P< 0.05). In the precore region, a higher frequency of the C1802, A1828, T1846, A1850, C1858, T1862, and A1896 mutations was found in HBeAg-negative patients (all; P< 0.05). In particular, the A1896 mutation was associated with high serum levels of ALT and HBV DNA in HBeAg-negative patients (P = 0.014 and 0.026, respectively). Mutations around the Kozak sequence (nucleotides 18091812) were found in 6.7% of patients and were not associated with undetectable HBeAg (P = 0.13). In Korean patients, various mutations in the precore and core promoter regions were associated with HBeAg escape and amelioration of hepatic inflammation in HBeAg-negative patients. Only the A1896 mutation contributed to HBeAg-negative chronic hepatitis B.

Original languageEnglish
Pages (from-to)594-601
Number of pages8
JournalJournal of Medical Virology
Volume81
Issue number4
DOIs
Publication statusPublished - 2009 Apr 1

Fingerprint

Hepatitis B e Antigens
Genetic Promoter Regions
Mutation
Hepatitis B virus
Chronic Hepatitis B
Hepatitis B Antibodies
Liver Function Tests
DNA
Virus Diseases
Hepatitis B Surface Antigens
Serum

All Science Journal Classification (ASJC) codes

  • Virology
  • Infectious Diseases

Cite this

Choi, Jong Won ; Ahn, SangHoon ; Park, Junyong ; Chang, Hye Young ; Kim, Ja Kyung ; Baatarkhuu, Oidov ; kim, doyoung ; Han, KwangHyub ; Chon, Chae Yoon. / Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients. In: Journal of Medical Virology. 2009 ; Vol. 81, No. 4. pp. 594-601.
@article{ac7914a8bddb425db6daa59b9445fb71,
title = "Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients",
abstract = "Most patients with hepatitis B e antigen (HBeAg)negative chronic hepatitis B have variants of the hepatitis B virus (HBV) that include mutations in the precore or core promoter regions of the HBV genome. The aim of this study was to investigate the patterns of precore and core promoter mutations and their relationship to HBeAg expression in Korean patients. Four hundred seventy-five Korean patients with chronic HBV infection between February 1995 and December 2003 were enrolled in this study. There were 236 HBeAg-positive and 239 HBeAg-negative patients. Blood samples were tested for HBsAg, anti-HBs, HBeAg, hepatitis B e antibody (anti-HBe), liver function tests, and serum HBV DNA. Mutations in the precore and core promoter regions were determined by direct sequencing. In the core promoter region, the C1740, C1753, T1762/A1764, and T1766 mutations were associated with HBeAg escape (all; P< 0.05). In the precore region, a higher frequency of the C1802, A1828, T1846, A1850, C1858, T1862, and A1896 mutations was found in HBeAg-negative patients (all; P< 0.05). In particular, the A1896 mutation was associated with high serum levels of ALT and HBV DNA in HBeAg-negative patients (P = 0.014 and 0.026, respectively). Mutations around the Kozak sequence (nucleotides 18091812) were found in 6.7{\%} of patients and were not associated with undetectable HBeAg (P = 0.13). In Korean patients, various mutations in the precore and core promoter regions were associated with HBeAg escape and amelioration of hepatic inflammation in HBeAg-negative patients. Only the A1896 mutation contributed to HBeAg-negative chronic hepatitis B.",
author = "Choi, {Jong Won} and SangHoon Ahn and Junyong Park and Chang, {Hye Young} and Kim, {Ja Kyung} and Oidov Baatarkhuu and doyoung kim and KwangHyub Han and Chon, {Chae Yoon}",
year = "2009",
month = "4",
day = "1",
doi = "10.1002/jmv.21452",
language = "English",
volume = "81",
pages = "594--601",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "4",

}

Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients. / Choi, Jong Won; Ahn, SangHoon; Park, Junyong; Chang, Hye Young; Kim, Ja Kyung; Baatarkhuu, Oidov; kim, doyoung; Han, KwangHyub; Chon, Chae Yoon.

In: Journal of Medical Virology, Vol. 81, No. 4, 01.04.2009, p. 594-601.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients

AU - Choi, Jong Won

AU - Ahn, SangHoon

AU - Park, Junyong

AU - Chang, Hye Young

AU - Kim, Ja Kyung

AU - Baatarkhuu, Oidov

AU - kim, doyoung

AU - Han, KwangHyub

AU - Chon, Chae Yoon

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Most patients with hepatitis B e antigen (HBeAg)negative chronic hepatitis B have variants of the hepatitis B virus (HBV) that include mutations in the precore or core promoter regions of the HBV genome. The aim of this study was to investigate the patterns of precore and core promoter mutations and their relationship to HBeAg expression in Korean patients. Four hundred seventy-five Korean patients with chronic HBV infection between February 1995 and December 2003 were enrolled in this study. There were 236 HBeAg-positive and 239 HBeAg-negative patients. Blood samples were tested for HBsAg, anti-HBs, HBeAg, hepatitis B e antibody (anti-HBe), liver function tests, and serum HBV DNA. Mutations in the precore and core promoter regions were determined by direct sequencing. In the core promoter region, the C1740, C1753, T1762/A1764, and T1766 mutations were associated with HBeAg escape (all; P< 0.05). In the precore region, a higher frequency of the C1802, A1828, T1846, A1850, C1858, T1862, and A1896 mutations was found in HBeAg-negative patients (all; P< 0.05). In particular, the A1896 mutation was associated with high serum levels of ALT and HBV DNA in HBeAg-negative patients (P = 0.014 and 0.026, respectively). Mutations around the Kozak sequence (nucleotides 18091812) were found in 6.7% of patients and were not associated with undetectable HBeAg (P = 0.13). In Korean patients, various mutations in the precore and core promoter regions were associated with HBeAg escape and amelioration of hepatic inflammation in HBeAg-negative patients. Only the A1896 mutation contributed to HBeAg-negative chronic hepatitis B.

AB - Most patients with hepatitis B e antigen (HBeAg)negative chronic hepatitis B have variants of the hepatitis B virus (HBV) that include mutations in the precore or core promoter regions of the HBV genome. The aim of this study was to investigate the patterns of precore and core promoter mutations and their relationship to HBeAg expression in Korean patients. Four hundred seventy-five Korean patients with chronic HBV infection between February 1995 and December 2003 were enrolled in this study. There were 236 HBeAg-positive and 239 HBeAg-negative patients. Blood samples were tested for HBsAg, anti-HBs, HBeAg, hepatitis B e antibody (anti-HBe), liver function tests, and serum HBV DNA. Mutations in the precore and core promoter regions were determined by direct sequencing. In the core promoter region, the C1740, C1753, T1762/A1764, and T1766 mutations were associated with HBeAg escape (all; P< 0.05). In the precore region, a higher frequency of the C1802, A1828, T1846, A1850, C1858, T1862, and A1896 mutations was found in HBeAg-negative patients (all; P< 0.05). In particular, the A1896 mutation was associated with high serum levels of ALT and HBV DNA in HBeAg-negative patients (P = 0.014 and 0.026, respectively). Mutations around the Kozak sequence (nucleotides 18091812) were found in 6.7% of patients and were not associated with undetectable HBeAg (P = 0.13). In Korean patients, various mutations in the precore and core promoter regions were associated with HBeAg escape and amelioration of hepatic inflammation in HBeAg-negative patients. Only the A1896 mutation contributed to HBeAg-negative chronic hepatitis B.

UR - http://www.scopus.com/inward/record.url?scp=62849112155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62849112155&partnerID=8YFLogxK

U2 - 10.1002/jmv.21452

DO - 10.1002/jmv.21452

M3 - Article

C2 - 19235871

AN - SCOPUS:62849112155

VL - 81

SP - 594

EP - 601

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 4

ER -